Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term rivaroxaban versus vitamin K antagonist after mechanical aortic valve replacement
KCT0005315Phase 4Recruiting
- Sponsor
- Cardiovascular Research Foundation
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rivaroxaban in aortic valve disease (AVD), sponsored by Cardiovascular Research Foundation. Started Feb 2022; status: recruiting.
02
Drugs
rivaroxaban
03
Conditions
aortic valve disease (AVD)
Beyond the preview
Go deeper on KCT0005315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0005315.